These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35059130)

  • 1. Discovery and Optimization of 7-Alkylidenyltetrahydroindazole-Based Acylsulfonamide EP3 Antagonists.
    Zhu B; Zhang X; Guo L; Rankin M; Bakaj I; Ho G; Lee SP; Norquay L; Macielag M
    ACS Med Chem Lett; 2022 Jan; 13(1):111-117. PubMed ID: 35059130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 Diabetes.
    Zhang X; Zhu B; Guo L; Bakaj I; Rankin M; Ho G; Kauffman J; Lee SP; Norquay L; Macielag MJ
    ACS Med Chem Lett; 2021 Mar; 12(3):451-458. PubMed ID: 33738072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.
    Lawrence RA; Jones RL
    Br J Pharmacol; 1992 Apr; 105(4):817-24. PubMed ID: 1324050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists.
    Jin J; Morales-Ramos A; Eidam P; Mecom J; Li Y; Brooks C; Hilfiker M; Zhang D; Wang N; Shi D; Tseng PS; Wheless K; Budzik B; Evans K; Jaworski JP; Jugus J; Leon L; Wu C; Pullen M; Karamshi B; Rao P; Ward E; Laping N; Evans C; Leach C; Holt D; Su X; Morrow D; Fries H; Thorneloe K; Edwards R
    ACS Med Chem Lett; 2010 Oct; 1(7):316-20. PubMed ID: 24900213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel N-acylsulfonamide analogs as potent and selective EP3 receptor antagonists.
    Asada M; Obitsu T; Kinoshita A; Nakai Y; Nagase T; Sugimoto I; Tanaka M; Takizawa H; Yoshikawa K; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2639-43. PubMed ID: 20346663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,4-Disubstituted indole acylsulfonamides: a novel series of potent and selective human EP3 receptor antagonists.
    Zhou N; Zeller W; Krohn M; Anderson H; Zhang J; Onua E; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
    Bioorg Med Chem Lett; 2009 Jan; 19(1):123-6. PubMed ID: 19022669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat prostaglandin EP3 receptor is highly promiscuous and is the sole prostanoid receptor family member that regulates INS-1 (832/3) cell glucose-stimulated insulin secretion.
    Sandhu HK; Neuman JC; Schaid MD; Davis SE; Connors KM; Challa R; Guthery E; Fenske RJ; Patibandla C; Breyer RM; Kimple ME
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00736. PubMed ID: 33694300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
    Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
    J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach.
    Araki H; Ukawa H; Sugawa Y; Yagi K; Suzuki K; Takeuchi K
    Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():116-24. PubMed ID: 10807413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostanoid EP3 receptor agonist sulprostone enhances pacemaker activity of colonic interstitial cells of Cajal.
    Kim MW; Jiao HY; Kim SW; Park CG; Wu MJ; Hong C; Choi S; Jun JY
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):961-969. PubMed ID: 28685234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor.
    Gu X; Xu J; Zhu L; Bryson T; Yang XP; Peterson E; Harding P
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27502370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E-type receptor subtypes and gastroduodenal bicarbonate secretion in rats.
    Takeuchi K; Yagi K; Kitamura M; Kubomi M; Tashima KI
    J Gastroenterol Hepatol; 1998 Nov; 13(S3):S221-S226. PubMed ID: 28976658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of a potent, well-balanced EP
    Kinoshita A; Higashino M; Yoshida K; Aratani Y; Kakuuchi A; Hanada K; Takeda H; Naganawa A; Matsuya H; Ohmoto K
    Bioorg Med Chem; 2018 Jan; 26(1):200-214. PubMed ID: 29203142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a prostanoid EP3-receptor in guinea-pig aorta: partial agonist action of the non-prostanoid ONO-AP-324.
    Jones RL; Qian YM; Chan KM; Yim AP
    Br J Pharmacol; 1998 Nov; 125(6):1288-96. PubMed ID: 9863659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of physicochemical properties of pyridone-based EP3 receptor antagonists.
    Zhang X; Zhu B; Guo L; Bakaj I; Rankin M; Ho G; Kauffman J; Lee SP; Norquay L; Macielag M
    Bioorg Med Chem Lett; 2021 Sep; 47():128172. PubMed ID: 34091043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptor.
    Burch JD; Belley M; Fortin R; Deschênes D; Girard M; Colucci J; Farand J; Therien AG; Mathieu MC; Denis D; Vigneault E; Lévesque JF; Gagné S; Wrona M; Xu D; Clark P; Rowland S; Han Y
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2048-54. PubMed ID: 18291643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship of biaryl acylsulfonamide analogues on the human EP(3) prostanoid receptor.
    Gallant M; Carrière MC; Chateauneuf A; Denis D; Gareau Y; Godbout C; Greig G; Juteau H; Lachance N; Lacombe P; Lamontagne S; Metters KM; Rochette C; Ruel R; Slipetz D; Sawyer N; Tremblay N; Labelle M
    Bioorg Med Chem Lett; 2002 Sep; 12(18):2583-6. PubMed ID: 12182865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Urea-1-(phenylmethyl)-pyridones as novel, potent, and selective EP3 receptor antagonists.
    Li YH; Tseng PS; Evans KA; Jaworski JP; Morrow DM; Fries HE; Wu CW; Edwards RM; Jin J
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6744-7. PubMed ID: 20926294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of prostaglandin E receptor EP3 subtype in duodenal bicarbonate secretion in rats.
    Aihara E; Nomura Y; Sasaki Y; Ise F; Kita K; Takeuchi K
    Life Sci; 2007 Jun; 80(26):2446-53. PubMed ID: 17512019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship of cinnamic acylsulfonamide analogues on the human EP3 prostanoid receptor.
    Juteau H; Gareau Y; Labelle M; Sturino CF; Sawyer N; Tremblay N; Lamontagne S; Carrière MC; Denis D; Metters KM
    Bioorg Med Chem; 2001 Aug; 9(8):1977-84. PubMed ID: 11504634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.